Cargando…
Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model
Adeno-associated virus (AAV) vectors expressing tumoricidal genes injected directly into brain tumors have shown some promise, however, invasive tumor cells are relatively unaffected. Systemic injection of AAV9 vectors provides widespread delivery to the brain and potentially the tumor/microenvironm...
Autores principales: | Crommentuijn, Matheus HW, Kantar, Rami, Noske, David P, Vandertop, W Peter, Badr, Christian E, Würdinger, Thomas, Maguire, Casey A, Tannous, Bakhos A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916948/ https://www.ncbi.nlm.nih.gov/pubmed/27382645 http://dx.doi.org/10.1038/mto.2016.17 |
Ejemplares similares
-
Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 – markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2015) -
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer
por: Lagerweij, Tonny, et al.
Publicado: (2016) -
Functional multiplex reporter assay using tagged Gaussia luciferase
por: van Rijn, Sjoerd, et al.
Publicado: (2013) -
Triple Bioluminescence Imaging for In Vivo Monitoring of Cellular Processes
por: Maguire, Casey A, et al.
Publicado: (2013) -
sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
por: Huang, Ying, et al.
Publicado: (2017)